News
ELTP
0.375
-1.24%
-0.005
Weekly Report: what happened at ELTP last week (0330-0403)?
Weekly Report · 1d ago
Elite launches generic methadone tablets, expanding pain portfolio
TipRanks · 4d ago
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Newsfile · 4d ago
Weekly Report: what happened at ELTP last week (0323-0327)?
Weekly Report · 03/30 09:36
Weekly Report: what happened at ELTP last week (0316-0320)?
Weekly Report · 03/23 09:34
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies
NASDAQ · 03/18 14:23
Top Stock Reports for GE Aerospace, Shell & McKesson
NASDAQ · 03/17 20:10
Weekly Report: what happened at ELTP last week (0309-0313)?
Weekly Report · 03/16 09:34
Weekly Report: what happened at ELTP last week (0302-0306)?
Weekly Report · 03/09 09:35
Weekly Report: what happened at ELTP last week (0223-0227)?
Weekly Report · 03/02 09:35
Weekly Report: what happened at ELTP last week (0216-0220)?
Weekly Report · 02/23 09:34
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
NASDAQ · 02/20 15:57
Elite Pharmaceuticals Delivers Strong Fiscal Q3 2026 Results
TipRanks · 02/17 23:19
Elite Pharmaceuticals GAAP EPS of $0.01, revenue of $31.6M
Seeking Alpha · 02/17 21:34
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
Newsfile · 02/17 21:19
Elite Pharmaceuticals Q3 EPS $0.01 Up From $(0.01) YoY, Sales $31.589M Up From $14.364M YoY
Benzinga · 02/17 21:12
Here are the major earnings after the close Tuesday
Seeking Alpha · 02/17 15:00
Weekly Report: what happened at ELTP last week (0209-0213)?
Weekly Report · 02/16 09:34
Elite Pharmaceuticals Schedules Q3 Fiscal 2026 Results Call
TipRanks · 02/11 22:05
Elite Pharmaceuticals Inc. to Release Third Quarter Financial Results and Host Corporate Update Conference Call
Reuters · 02/11 21:32
More
Webull provides a variety of real-time ELTP stock news. You can receive the latest news about Elite Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About ELTP
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.